Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial von Shaverdian, Narek, MD, Lisberg, Aaron E, MD, Bornazyan, Krikor, MD, Veruttipong, Darlene, MPH, Goldman, Jonathan W, MD, Formenti, Silvia C, MD, Garon, Edward B, MD, Lee, Percy, Dr

Volltext

Biophysical isolation and identification of circulating tumor cells von Che, James, Yu, Victor, Garon, Edward B, Goldman, Jonathan W, Di Carlo, Dino

Volltext

Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer von Gettinger, Scott, Rizvi, Naiyer A, Chow, Laura Q, Borghaei, Hossein, Brahmer, Julie, Ready, Neal, Gerber, David E, Shepherd, Frances A, Antonia, Scott, Goldman, Jonathan W, Juergens, Rosalyn A, Laurie, Scott A, Nathan, Faith E, Shen, Yun, Harbison, Christopher T, Hellmann, Matthew D

Volltext

Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study von Garon, Edward B, Hellmann, Matthew D, Rizvi, Naiyer A, Carcereny, Enric, Leighl, Natasha B, Ahn, Myung-Ju, Eder, Joseph Paul, Balmanoukian, Ani S, Aggarwal, Charu, Horn, Leora, Patnaik, Amita, Gubens, Matthew, Ramalingam, Suresh S, Felip, Enriqueta, Goldman, Jonathan W, Scalzo, Cathie, Jensen, Erin, Kush, Debra A, Hui, Rina

Volltext

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC von Tsuboi, Masahiro, Herbst, Roy S., John, Thomas, Kato, Terufumi, Majem, Margarita, Grohé, Christian, Wang, Jie, Goldman, Jonathan W., Lu, Shun, Su, Wu-Chou, de Marinis, Filippo, Shepherd, Frances A., Lee, Ki Hyeong, Le, Nhieu Thi, Dechaphunkul, Arunee, Kowalski, Dariusz, Poole, Lynne, Bolanos, Ana, Rukazenkov, Yuri, Wu, Yi-Long

Volltext

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer von Wu, Yi-Long, Tsuboi, Masahiro, He, Jie, John, Thomas, Grohe, Christian, Majem, Margarita, Goldman, Jonathan W, Laktionov, Konstantin, Kim, Sang-We, Kato, Terufumi, Vu, Huu-Vinh, Lu, Shun, Lee, Kye-Young, Akewanlop, Charuwan, Yu, Chong-Jen, de Marinis, Filippo, Bonanno, Laura, Domine, Manuel, Shepherd, Frances A, Zeng, Lingmin, Hodge, Rachel, Atasoy, Ajlan, Rukazenkov, Yuri, Herbst, Roy S

Volltext

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study von Hellmann, Matthew D, Dr, Rizvi, Naiyer A, Prof, Goldman, Jonathan W, MD, Gettinger, Scott N, MD, Borghaei, Hossein, DO, Brahmer, Julie R, MD, Ready, Neal E, Prof, Gerber, David E, MD, Chow, Laura Q, MD, Juergens, Rosalyn A, MD, Shepherd, Frances A, Prof, Laurie, Scott A, MD, Geese, William J, PhD, Agrawal, Shruti, PhD, Young, Tina C, MS, Li, Xuemei, MD, Antonia, Scott J, Prof

Volltext

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial von Herbst, Roy S, Wu, Yi-Long, John, Thomas, Grohe, Christian, Majem, Margarita, Wang, Jie, Kato, Terufumi, Goldman, Jonathan W, Laktionov, Konstantin, Kim, Sang-We, Yu, Chong-Jen, Vu, Huu Vinh, Lu, Shun, Lee, Kye Young, Mukhametshina, Guzel, Akewanlop, Charuwan, de Marinis, Filippo, Bonanno, Laura, Domine, Manuel, Shepherd, Frances A, Urban, Damien, Huang, Xiangning, Bolanos, Ana, Stachowiak, Marta, Tsuboi, Masahiro

Volltext

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC von Wu, Yi-Long, John, Thomas, Grohe, Christian, Majem, Margarita, Goldman, Jonathan W., Kim, Sang-We, Kato, Terufumi, Laktionov, Konstantin, Vu, Huu Vinh, Wang, Zhijie, Lu, Shun, Lee, Kye Young, Akewanlop, Charuwan, Yu, Chong-Jen, de Marinis, Filippo, Bonanno, Laura, Domine, Manuel, Shepherd, Frances A., Zeng, Lingmin, Atasoy, Ajlan, Herbst, Roy S., Tsuboi, Masahiro

Volltext

Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study von Yang, James C H, Kim, Sang-We, Kim, Dong-Wan, Lee, Jong-Seok, Cho, Byoung Chul, Ahn, Jin-Seok, Lee, Dae H, Kim, Tae Min, Goldman, Jonathan W, Natale, Ronald B, Brown, Andrew P, Collins, Barbara, Chmielecki, Juliann, Vishwanathan, Karthick, Mendoza-Naranjo, Ariadna, Ahn, Myung-Ju

Volltext

Combination treatment options for small-cell lung cancer – Authors' reply von Goldman, Jonathan W, Paz-Ares, Luis

Volltext

Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial von Le, Xiuning, Cornelissen, Robin, Garassino, Marina, Clarke, Jeffrey M, Tchekmedyian, Nishan, Goldman, Jonathan W, Leu, Szu-Yun, Bhat, Gajanan, Lebel, Francois, Heymach, John V, Socinski, Mark A

Volltext

Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer von Rizvi, Naiyer A, Hellmann, Matthew D, Brahmer, Julie R, Juergens, Rosalyn A, Borghaei, Hossein, Gettinger, Scott, Chow, Laura Q, Gerber, David E, Laurie, Scott A, Goldman, Jonathan W, Shepherd, Frances A, Chen, Allen C, Shen, Yun, Nathan, Faith E, Harbison, Christopher T, Antonia, Scott

Volltext

Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer von Dhar, Manjima, Wong, Jessica, Che, James, Matsumoto, Melissa, Grogan, Tristan, Elashoff, David, Garon, Edward B., Goldman, Jonathan W., Sollier Christen, Elodie, Di Carlo, Dino, Kulkarni, Rajan P.

Volltext

Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686) von Karlovich, Chris, Goldman, Jonathan W, Sun, Jong-Mu, Mann, Elaina, Sequist, Lecia V, Konopa, Krzysztof, Wen, Wei, Angenendt, Philipp, Horn, Leora, Spigel, David, Soria, Jean-Charles, Solomon, Benjamin, Camidge, D Ross, Gadgeel, Shirish, Paweletz, Cloud, Wu, Lin, Chien, Sean, O'Donnell, Patrick, Matheny, Shannon, Despain, Darrin, Rolfe, Lindsey, Raponi, Mitch, Allen, Andrew R, Park, Keunchil, Wakelee, Heather

Volltext

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer von Garon, Edward B, Rizvi, Naiyer A, Hui, Rina, Leighl, Natasha, Balmanoukian, Ani S, Eder, Joseph Paul, Patnaik, Amita, Aggarwal, Charu, Gubens, Matthew, Horn, Leora, Carcereny, Enric, Ahn, Myung-Ju, Felip, Enriqueta, Lee, Jong-Seok, Hellmann, Matthew D, Hamid, Omid, Goldman, Jonathan W, Soria, Jean-Charles, Dolled-Filhart, Marisa, Rutledge, Ruth Z, Zhang, Jin, Lunceford, Jared K, Rangwala, Reshma, Lubiniecki, Gregory M, Roach, Charlotte, Emancipator, Kenneth, Gandhi, Leena

Volltext

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions von Zhou, Caicun, Tang, Ke-Jing, Cho, Byoung Chul, Liu, Baogang, Paz-Ares, Luis, Cheng, Susanna, Kitazono, Satoru, Thiagarajan, Muthukkumaran, Goldman, Jonathan W, Sabari, Joshua K, Sanborn, Rachel E, Mansfield, Aaron S, Hung, Jen-Yu, Boyer, Michael, Popat, Sanjay, Mourão Dias, Josiane, Felip, Enriqueta, Majem, Margarita, Gumus, Mahmut, Kim, Sang-We, Ono, Akira, Xie, John, Bhattacharya, Archan, Agrawal, Trishala, Shreeve, S Martin, Knoblauch, Roland E, Park, Keunchil, Girard, Nicolas

Volltext

Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer von Camidge, D Ross, Barlesi, Fabrice, Goldman, Jonathan W, Morgensztern, Daniel, Heist, Rebecca, Vokes, Everett, Spira, Alex, Angevin, Eric, Su, Wu-Chou, Hong, David S, Strickler, John H, Motwani, Monica, Dunbar, Martin, Parikh, Apurvasena, Noon, Elysa, Blot, Vincent, Wu, Jun, Kelly, Karen

Volltext

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors von Patnaik, Amita, Rosen, Lee S, Tolaney, Sara M, Tolcher, Anthony W, Goldman, Jonathan W, Gandhi, Leena, Papadopoulos, Kyriakos P, Beeram, Muralidhar, Rasco, Drew W, Hilton, John F, Nasir, Aejaz, Beckmann, Richard P, Schade, Andrew E, Fulford, Angie D, Nguyen, Tuan S, Martinez, Ricardo, Kulanthaivel, Palaniappan, Li, Lily Q, Frenzel, Martin, Cronier, Damien M, Chan, Edward M, Flaherty, Keith T, Wen, Patrick Y, Shapiro, Geoffrey I

Volltext

Size-selective collection of circulating tumor cells using Vortex technology von Sollier, Elodie, Go, Derek E, Che, James, Gossett, Daniel R, O'Byrne, Sean, Weaver, Westbrook M, Kummer, Nicolas, Rettig, Matthew, Goldman, Jonathan, Nickols, Nicholas, McCloskey, Susan, Kulkarni, Rajan P, Di Carlo, Dino

Volltext